Comprehensive Review of Mucormycosis: Epidemiology, Clinical Manifestations, Risk Factors, and Post-COVID-19 Insights Across Global and Indian Perspectives

Key Points

• Mucormycosis cases have surged significantly in the context of post-COVID-19 complications across various regions.
• In India, the incidence of mucormycosis rose sharply, particularly among individuals with diabetes or other comorbidities.
• Epidemiological factors highlight a concerning link between COVID-19 and increased risk for mucormycosis, demanding urgent public health action.
• Understanding clinical manifestations of mucormycosis in post-COVID-19 patients is critical for effective diagnosis and treatment.